source
- Hims sales dip as telehealth rivals intensify; Bristol partners with Chinese firm, other biotech updatesHims reported lower sales this quarter, attributing the shortfall to growing competition from other telehealth providers. Bristol announced a new partnership with Chinese drugmaker Hengrui Pharma…
- FDA grants breakthrough therapy designation to Emi-Le for advanced adenoid cystic carcinomaThe U.S. Food and Drug Administration has granted breakthrough therapy designation to Emi-Le for patients with locally advanced, recurrent or metastatic adenoid cystic carcinoma (ACC). Phase 1 tri…